Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis A Comparative Consecutive Series

Lauren A. Dalvin, Fernando C. Fervenza, Sanjeev Sethi, Jose S. Pulido

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Purpose Membranoproliferative glomerulonephritis (MPGN) recently was reclassified to reflect the underlying cause as a complement-mediated and immune complex-mediated disease. This classification is based on renal biopsy immunofluorescence examination, making the former electron-microscopy classification obsolete. In this report, we describe related eye findings in patients with MPGN based on the new classification. Design Retrospective case series. Participants All Mayo Clinic Rochester patients with pathology-confirmed complement- and immune complex-mediated MPGN who had available ophthalmology records from 1997 through 2014 were included in this study. Methods The medical and pathologic records of patients with MPGN and eye examination results were reviewed from years 1997 through 2014. Main Outcome Measures The number of patients and the number of eyes with MPGN-related pathologic features were examined. Visual acuity also was considered. Results There were 23 patients with complement-mediated MPGN and available eye examination results. Of these, 9 patients (39%) and 17 eyes (37%) had retinal pathologic features that likely were related to the same underlying pathophysiologic process as their renal disease. Five patients (22%) and 6 eyes (13%) had significant vision loss. There were 23 patients with immune complex-mediated MPGN and available eye examination results. Only 2 (9%) of these patients (4 eyes) had retinal pathologic features that potentially could be related to the same underlying pathophysiologic process as their renal disease, and neither had vision loss. Conclusions Retinal abnormalities are more prominent among patients with complement-mediated MPGN when compared with patients with immune complex-mediated MPGN. It is critical for ophthalmologists to recognize the updated MPGN classification system, and all patients with complement-mediated MPGN require screening eye examinations.

Original languageEnglish (US)
Pages (from-to)1588-1594
Number of pages7
JournalOphthalmology
Volume123
Issue number7
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint

Dive into the research topics of 'Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis A Comparative Consecutive Series'. Together they form a unique fingerprint.

Cite this